药明康德

- 603259

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
药明康德(603259) 利润表
单位:万元
报表日期2023-12-312023-09-302023-06-302023-03-312022-12-31
一、营业总收入4,034,080.692,954,132.611,887,128.55896,374.163,935,477.78
营业收入4,034,080.692,954,132.611,887,128.55896,374.163,935,477.78
二、营业总成本2,870,859.082,039,075.491,315,519.22677,522.862,980,081.07
营业成本2,372,879.961,734,130.721,122,547.78538,788.152,467,721.68
营业税金及附加29,747.9417,599.0111,690.086,028.0920,047.44
销售费用70,102.9752,122.0435,347.4117,585.3873,158.66
管理费用287,877.08197,987.56127,285.2164,904.27282,554.75
财务费用-33,811.92-65,344.95-48,055.7714,486.87-24,796.81
研发费用144,063.04102,581.1166,704.5035,730.10161,395.34
资产减值损失----------
公允价值变动收益-3,780.9110,267.6131,099.2116,460.8577,007.86
投资收益23,384.9046,343.6932,022.2717,755.9318,794.90
其中:对联营企业和合营企业的投资收益-6,755.99-5,158.31-6,877.89-3,750.05-4,627.11
汇兑收益----------
三、营业利润1,187,228.59980,741.65641,244.05261,535.481,065,224.85
加:营业外收入1,659.63662.43494.04381.44964.50
减:营业外支出5,689.123,207.452,216.801,029.654,341.71
其中:非流动资产处置损失----------
四、利润总额1,183,199.10978,196.63639,521.29260,887.281,061,847.65
减:所得税费用213,173.10163,331.92103,831.6742,306.81171,586.59
五、净利润970,026.00814,864.71535,689.62218,580.46890,261.05
归属于母公司所有者的净利润960,674.91807,640.72531,311.97216,812.84881,371.30
少数股东损益9,351.097,223.994,377.651,767.638,889.75
六、每股收益
基本每股收益(元/股)3.27002.75001.81000.74003.0100
稀释每股收益(元/股)3.24002.73001.79000.72002.8200
七、其他综合收益8,692.09-54,393.58-51,366.85-1,791.5829,310.80
八、综合收益总额978,718.09760,471.13484,322.77216,788.88919,571.86
归属于母公司所有者的综合收益总额969,505.24754,124.38480,696.65214,960.14910,913.80
归属于少数股东的综合收益总额9,212.856,346.763,626.121,828.748,658.06
下载全部历史数据到excel中 返回页顶